4 news items
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated
PRPH
9 May 24
. (NASDAQ:PRPH) ("ProPhase") is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
PRPH
9 May 24
, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We're revolutionizing healthcare
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PRPH
1 Apr 24
. (NASDAQ:PRPH) is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
PRPH
8 Mar 24
. (NASDAQ:PRPH) ("ProPhase") is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world
- Prev
- 1
- Next